Literature DB >> 11495349

Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists.

M Lysíková1, Z Havlas, S Tucek.   

Abstract

Allosteric enhancement of the affinity of muscarinic receptors for their ligands offers a new way to influence cholinergic neurotransmission. The structure of the allosteric binding domain(s) and the features of agonists, antagonists and modulators which determine the occurrence of either positive or negative cooperativity require clarification. We tested interactions between allosteric modulators alcuronium, strychnine and brucine and eight antagonists at muscarinic receptors expressed in CHO cells. In experiments with unlabeled antagonists, all three modulators enhanced the affinity for 4-diphenylacetoxy-N-dimethylpiperidinium (4-DAMP) at the M2 receptors, and strychnine did so also at the M4 receptors. Positive interactions were also observed between alcuronium and L-hyoscyamine (M2) and scopolamine (M2), between strychnine and butylscopolamine (M4), L-hyoscyamine (M2 and M4) and scopolamine (M4), and between brucine and scopolamine (M2). Positive effects of alcuronium, strychnine and brucine on the affinity of the M2 receptors for 4-DAMP have been confirmed by direct measurements of the binding of [3H]-4-DAMP. A comparison of molecular models of several antagonists which are esters revealed that antagonists in which the distance between the N and the carboxyl C atoms corresponds to five chemical bonds are more likely to display positive cooperativity with alcuronium at the M2 receptors than the antagonists in which the N-carboxyl C distance corresponds to four chemical bonds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11495349     DOI: 10.1023/a:1010951131496

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

1.  Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.

Authors:  J Jakubík; L Bacáková; E E El-Fakahany; S Tucek
Journal:  Mol Pharmacol       Date:  1997-07       Impact factor: 4.436

2.  Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxillic acid esters.

Authors:  M Lysíková; K Fuksová; T Elbert; J Jakubík; S Tucek
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 3.  Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes.

Authors:  N J Birdsall; T Farries; P Gharagozloo; S Kobayashi; D Kuonen; S Lazareno; A Popham; M Sugimoto
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

4.  Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors.

Authors:  A L Gnagey; M Seidenberg; J Ellis
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

5.  Positive and negative allosteric interactions on muscarinic receptors.

Authors:  L Hejnová; S Tucek; E E el-Fakahany
Journal:  Eur J Pharmacol       Date:  1995-11-30       Impact factor: 4.432

6.  Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site.

Authors:  S Lazareno; A Popham; N J Birdsall
Journal:  Mol Pharmacol       Date:  2000-07       Impact factor: 4.436

7.  The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptor agonists.

Authors:  V Dolezal; S Tucek
Journal:  Br J Pharmacol       Date:  1998-07       Impact factor: 8.739

8.  Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.

Authors:  J Proska; S Tucek
Journal:  Mol Pharmacol       Date:  1994-04       Impact factor: 4.436

9.  Ligand binding properties of muscarinic acetylcholine receptor subtypes (m1-m5) expressed in baculovirus-infected insect cells.

Authors:  G Z Dong; K Kameyama; A Rinken; T Haga
Journal:  J Pharmacol Exp Ther       Date:  1995-07       Impact factor: 4.030

10.  Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Authors:  F Dörje; J Wess; G Lambrecht; R Tacke; E Mutschler; M R Brann
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

View more
  5 in total

Review 1.  Allosteric drugs acting at muscarinic acetylcholine receptors.

Authors:  Magali Waelbroeck
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Cooperative interactions at M2 muscarinic acetylcholine receptors: structure/activity relationships in stepwise shortened bispyridinium- and bis(ammonio)alkane-type allosteric modulators.

Authors:  Ralf Gilsbach; Maren Grossmüller; Vildan Alptüzün; Ercin Erciyas; Christian Tränkle; Ulrike Holzgrabe; Klaus Mohr
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

3.  Heterotropic cooperativity within and between protomers of an oligomeric M(2) muscarinic receptor.

Authors:  Rabindra V Shivnaraine; Xi-Ping Huang; Margaret Seidenberg; John Ellis; James W Wells
Journal:  Biochemistry       Date:  2012-05-24       Impact factor: 3.162

Review 4.  Allosteric Modulation of Muscarinic Acetylcholine Receptors.

Authors:  Jan Jakubík; Esam E El-Fakahany
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-30

5.  Luciferase activity under direct ligand-dependent control of a muscarinic acetylcholine receptor.

Authors:  Doreen Thor; Diana Le Duc; Rainer Strotmann; Torsten Schöneberg
Journal:  BMC Biotechnol       Date:  2009-05-18       Impact factor: 2.563

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.